Copyright Reports & Markets. All rights reserved.

Global Attention Deficit Hyperactivity Disorder Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Attention Deficit Hyperactivity Disorder

      • 1.1 Definition of Attention Deficit Hyperactivity Disorder
      • 1.2 Attention Deficit Hyperactivity Disorder Segment by Type
        • 1.2.1 Global Attention Deficit Hyperactivity Disorder Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Stimulants Drugs
        • 1.2.3 Non-stimulants Drugs
      • 1.3 Attention Deficit Hyperactivity Disorder Segment by Applications
        • 1.3.1 Global Attention Deficit Hyperactivity Disorder Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Pediatric
        • 1.3.3 Adolescent
        • 1.3.4 Adults
      • 1.4 Global Attention Deficit Hyperactivity Disorder Overall Market
        • 1.4.1 Global Attention Deficit Hyperactivity Disorder Revenue (2014-2025)
        • 1.4.2 Global Attention Deficit Hyperactivity Disorder Production (2014-2025)
        • 1.4.3 North America Attention Deficit Hyperactivity Disorder Status and Prospect (2014-2025)
        • 1.4.4 Europe Attention Deficit Hyperactivity Disorder Status and Prospect (2014-2025)
        • 1.4.5 China Attention Deficit Hyperactivity Disorder Status and Prospect (2014-2025)
        • 1.4.6 Japan Attention Deficit Hyperactivity Disorder Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Attention Deficit Hyperactivity Disorder Status and Prospect (2014-2025)
        • 1.4.8 India Attention Deficit Hyperactivity Disorder Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Attention Deficit Hyperactivity Disorder
      • 2.3 Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder
      • 2.4 Industry Chain Structure of Attention Deficit Hyperactivity Disorder

      3 Development and Manufacturing Plants Analysis of Attention Deficit Hyperactivity Disorder

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Attention Deficit Hyperactivity Disorder Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Attention Deficit Hyperactivity Disorder
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Attention Deficit Hyperactivity Disorder Production and Capacity Analysis
      • 4.2 Attention Deficit Hyperactivity Disorder Revenue Analysis
      • 4.3 Attention Deficit Hyperactivity Disorder Price Analysis
      • 4.4 Market Concentration Degree

      5 Attention Deficit Hyperactivity Disorder Regional Market Analysis

      • 5.1 Attention Deficit Hyperactivity Disorder Production by Regions
        • 5.1.1 Global Attention Deficit Hyperactivity Disorder Production by Regions
        • 5.1.2 Global Attention Deficit Hyperactivity Disorder Revenue by Regions
      • 5.2 Attention Deficit Hyperactivity Disorder Consumption by Regions
      • 5.3 North America Attention Deficit Hyperactivity Disorder Market Analysis
        • 5.3.1 North America Attention Deficit Hyperactivity Disorder Production
        • 5.3.2 North America Attention Deficit Hyperactivity Disorder Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Attention Deficit Hyperactivity Disorder Import and Export
      • 5.4 Europe Attention Deficit Hyperactivity Disorder Market Analysis
        • 5.4.1 Europe Attention Deficit Hyperactivity Disorder Production
        • 5.4.2 Europe Attention Deficit Hyperactivity Disorder Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Attention Deficit Hyperactivity Disorder Import and Export
      • 5.5 China Attention Deficit Hyperactivity Disorder Market Analysis
        • 5.5.1 China Attention Deficit Hyperactivity Disorder Production
        • 5.5.2 China Attention Deficit Hyperactivity Disorder Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Attention Deficit Hyperactivity Disorder Import and Export
      • 5.6 Japan Attention Deficit Hyperactivity Disorder Market Analysis
        • 5.6.1 Japan Attention Deficit Hyperactivity Disorder Production
        • 5.6.2 Japan Attention Deficit Hyperactivity Disorder Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Attention Deficit Hyperactivity Disorder Import and Export
      • 5.7 Southeast Asia Attention Deficit Hyperactivity Disorder Market Analysis
        • 5.7.1 Southeast Asia Attention Deficit Hyperactivity Disorder Production
        • 5.7.2 Southeast Asia Attention Deficit Hyperactivity Disorder Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Attention Deficit Hyperactivity Disorder Import and Export
      • 5.8 India Attention Deficit Hyperactivity Disorder Market Analysis
        • 5.8.1 India Attention Deficit Hyperactivity Disorder Production
        • 5.8.2 India Attention Deficit Hyperactivity Disorder Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Attention Deficit Hyperactivity Disorder Import and Export

      6 Attention Deficit Hyperactivity Disorder Segment Market Analysis (by Type)

      • 6.1 Global Attention Deficit Hyperactivity Disorder Production by Type
      • 6.2 Global Attention Deficit Hyperactivity Disorder Revenue by Type
      • 6.3 Attention Deficit Hyperactivity Disorder Price by Type

      7 Attention Deficit Hyperactivity Disorder Segment Market Analysis (by Application)

      • 7.1 Global Attention Deficit Hyperactivity Disorder Consumption by Application
      • 7.2 Global Attention Deficit Hyperactivity Disorder Consumption Market Share by Application (2014-2019)

      8 Attention Deficit Hyperactivity Disorder Major Manufacturers Analysis

      • 8.1 Eli Lilly
        • 8.1.1 Eli Lilly Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.1.2 Eli Lilly Product Introduction, Application and Specification
        • 8.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Shire
        • 8.3.1 Shire Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.3.2 Shire Product Introduction, Application and Specification
        • 8.3.3 Shire Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Pfizer
        • 8.4.1 Pfizer Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.4.2 Pfizer Product Introduction, Application and Specification
        • 8.4.3 Pfizer Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 GlaxoSmithKline
        • 8.5.1 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.5.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Mallinckrodt
        • 8.6.1 Mallinckrodt Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.6.2 Mallinckrodt Product Introduction, Application and Specification
        • 8.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Hisamitsu
        • 8.7.1 Hisamitsu Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.7.2 Hisamitsu Product Introduction, Application and Specification
        • 8.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Impax
        • 8.8.1 Impax Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.8.2 Impax Product Introduction, Application and Specification
        • 8.8.3 Impax Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Johnson & Johnson
        • 8.9.1 Johnson & Johnson Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.9.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.9.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 UCB
        • 8.10.1 UCB Attention Deficit Hyperactivity Disorder Production Sites and Area Served
        • 8.10.2 UCB Product Introduction, Application and Specification
        • 8.10.3 UCB Attention Deficit Hyperactivity Disorder Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Purdue Parma

      9 Development Trend of Analysis of Attention Deficit Hyperactivity Disorder Market

      • 9.1 Global Attention Deficit Hyperactivity Disorder Market Trend Analysis
        • 9.1.1 Global Attention Deficit Hyperactivity Disorder Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Attention Deficit Hyperactivity Disorder Regional Market Trend
        • 9.2.1 North America Attention Deficit Hyperactivity Disorder Forecast 2019-2025
        • 9.2.2 Europe Attention Deficit Hyperactivity Disorder Forecast 2019-2025
        • 9.2.3 China Attention Deficit Hyperactivity Disorder Forecast 2019-2025
        • 9.2.4 Japan Attention Deficit Hyperactivity Disorder Forecast 2019-2025
        • 9.2.5 Southeast Asia Attention Deficit Hyperactivity Disorder Forecast 2019-2025
        • 9.2.6 India Attention Deficit Hyperactivity Disorder Forecast 2019-2025
      • 9.3 Attention Deficit Hyperactivity Disorder Market Trend (Product Type)
      • 9.4 Attention Deficit Hyperactivity Disorder Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Attention Deficit Hyperactivity Disorder Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.

        The global Attention Deficit Hyperactivity Disorder market was valued at 16800 million US$ in 2018 and will reach 27100 million US$ by the end of 2025, growing at a CAGR of 6.2% during 2019-2025.
        This report focuses on Attention Deficit Hyperactivity Disorder volume and value at global level, regional level and company level. From a global perspective, this report represents overall Attention Deficit Hyperactivity Disorder market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Attention Deficit Hyperactivity Disorder in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Attention Deficit Hyperactivity Disorder manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Eli Lilly
        Novartis
        Shire
        Pfizer
        GlaxoSmithKline
        Mallinckrodt
        Hisamitsu
        Impax
        Johnson & Johnson
        UCB
        Purdue Parma

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Stimulants Drugs
        Non-stimulants Drugs

        Segment by Application
        Pediatric
        Adolescent
        Adults

        Buy now